Vestiio consistency score
Vestiio follows each manager’s 13F filings from the day they became public and scores how the disclosed positions went on to do against other managers filing for the same quarter. Beating the field repeatedly, over up to five years, counts for more than one strong quarter. The top of the latest ranking scores 66.0.
Farallon Capital Management has no consistency score in the latest ranking. A score needs at least twelve completed quarters, each with at least 70% of the book mapped to listed securities with daily prices and an average of at least 80% across them, and at least a quarter of the book in its ten largest positions.
Latest reported holdings
151 positions worth $21.2 billion for the quarter ending 31 December 2025. The ten largest make up 46.9% of the book.
| Company | Reported value | Share of book |
|---|---|---|
| State Street® SPDR® S&P 500® ETF TrustSPY, put options, valued at the underlying shares | $2.0 billion | 9.7% |
| Revolution Medicines IncRVMD | $1.2 billion | 5.5% |
| Microsoft CorporationMSFT | $1.1 billion | 5.1% |
| Amazon.com IncAMZN | $1.0 billion | 4.9% |
| Aon PLCAON | $940.5 million | 4.4% |
| Natera IncNTRA | $896.7 million | 4.2% |
| Boston Scientific CorpBSX | $709.4 million | 3.3% |
| Invesco S&P 500® Equal Weight ETFRSP, put options, valued at the underlying shares | $689.6 million | 3.3% |
| Exelixis IncEXEL | $688.5 million | 3.2% |
| BridgeBio Pharma IncBBIO | $688.3 million | 3.2% |
| iShares iBoxx $ High Yield Corporate Bond ETFHYG, put options, valued at the underlying shares | $645.0 million | 3.0% |
| Protagonist Therapeutics IncPTGX | $536.6 million | 2.5% |
| Westinghouse Air Brake Technologies CorpWAB | $528.5 million | 2.5% |
| UnitedHealth Group IncorporatedUNH | $527.8 million | 2.5% |
| CyberArk Software LtdCYBR | $469.7 million | 2.2% |
| Walt Disney CompanyDIS | $469.4 million | 2.2% |
| Synopsys IncSNPS | $469.3 million | 2.2% |
| Eli Lilly and CompanyLLY, put options, valued at the underlying shares | $403.0 million | 1.9% |
| Thermo Fisher Scientific IncTMO | $368.3 million | 1.7% |
| Lantheus Holdings IncLNTH | $361.2 million | 1.7% |
| Aramark HoldingsARMK | $344.9 million | 1.6% |
| Salesforce.com IncCRM | $334.1 million | 1.6% |
| Charles Schwab CorpSCHW | $333.7 million | 1.6% |
| Crinetics Pharmaceuticals IncCRNX | $322.7 million | 1.5% |
| Broadcom IncAVGO | $308.9 million | 1.5% |
| Liquidia Technologies IncLQDA | $298.5 million | 1.4% |
| Nasdaq IncNDAQ | $290.3 million | 1.4% |
| Beam Therapeutics IncBEAM | $278.9 million | 1.3% |
| KKR & Co. Inc.KKR | $257.2 million | 1.2% |
| Alphabet Inc Class CGOOG | $247.0 million | 1.2% |
| McKesson CorporationMCK | $245.2 million | 1.2% |
| Visa Inc. Class AV | $244.1 million | 1.2% |
| New York Times CompanyNYT | $227.7 million | 1.1% |
| Dayforce Inc.DAY | $202.3 million | 1.0% |
| GRAIL, LLCGRAL | $200.5 million | 0.9% |
| Bitwise 10 Crypto Index ETFBITW | $198.9 million | 0.9% |
| CBRE Group Inc Class ACBRE | $158.2 million | 0.7% |
| Agios PharmAGIO | $140.4 million | 0.7% |
| Centessa Pharmaceuticals PLC ADRCNTA | $134.5 million | 0.6% |
| Beta Bionics, Inc. Common StockBBNX | $131.4 million | 0.6% |
| Cardinal Health IncCAH | $118.4 million | 0.6% |
| Tango Therapeutics IncTNGX | $115.7 million | 0.5% |
| Hims Hers Health IncHIMS | $110.0 million | 0.5% |
| iShares iBonds 1-5 Year Corporate Ladder ETFIBIT | $106.1 million | 0.5% |
| Mastercard IncMA | $98.6 million | 0.5% |
| CIDARA THERAPEUTICS INC | $84.6 million | 0.4% |
| Tenet Healthcare CorporationTHC | $74.0 million | 0.3% |
| Welltower IncWELL | $63.7 million | 0.3% |
| TransUnionTRU | $57.9 million | 0.3% |
| Tyra Biosciences IncTYRA | $54.3 million | 0.3% |
| VNET Group Inc DRCVNET | $53.2 million | 0.3% |
| Abivax SA American Depositary SharesAAVXF | $52.2 million | 0.2% |
| Enanta Pharmaceuticals IncENTA | $43.7 million | 0.2% |
| Insmed IncINSM, call options, valued at the underlying shares | $43.5 million | 0.2% |
| Assembly Biosciences IncASMB | $41.8 million | 0.2% |
| Baidu IncBIDU | $41.2 million | 0.2% |
| Alnylam Pharmaceuticals IncALNY, put options, valued at the underlying shares | $39.8 million | 0.2% |
| JOYY INC | $37.4 million | 0.2% |
| ISHARES ETHEREUM TR | $33.2 million | 0.2% |
| Structure Therapeutics Inc. American Depositary SharesGPCR | $31.6 million | 0.1% |
| Mineralys Therapeutics, Inc. Common StockMLYS | $29.9 million | 0.1% |
| SUNOCOCORP LLC | $29.9 million | 0.1% |
| PERCEPTIVE CAP SOLUTIONS COR | $29.3 million | 0.1% |
| Terns Pharmaceuticals IncTERN | $25.9 million | 0.1% |
| Encompass Health CorpEHC | $24.9 million | 0.1% |
| Amkor Technology IncAMKR | $18.3 million | 0.1% |
| Verastem IncVSTM | $15.4 million | 0.1% |
| Doximity IncDOCS | $13.8 million | 0.1% |
| Guardant Health IncGH | $11.1 million | 0.1% |
| MEDLINE INC | $10.9 million | 0.1% |
| New Oriental Education & TechnologyEDU | $10.8 million | 0.1% |
| Minerva Neurosciences IncNERV | $9.5 million | under 0.1% |
| GeneDx Holdings Corp.WGS | $9.1 million | under 0.1% |
| GRAYSCALE ETHEREUM MINI TR E | $6.4 million | under 0.1% |
| Prime Medicine, Inc. Common StockPRME | $4.3 million | under 0.1% |
| Oscar Health IncOSCR | $3.8 million | under 0.1% |
| Madrigal Pharmaceuticals IncMDGL | $1.9 million | under 0.1% |
| Summit Midstream CorporationSMC | $1.6 million | under 0.1% |
| Novavax IncNVAX | $1.3 million | under 0.1% |
| Schrodinger IncSDGR | $1.3 million | under 0.1% |
| Teva Pharma Industries Ltd ADRTEVA | $1.2 million | under 0.1% |
| Capricor Therapeutics IncCAPR | $1.2 million | under 0.1% |
| Arrowhead Pharmaceuticals IncARWR | $1.0 million | under 0.1% |
| ALVOTECH | $1.0 million | under 0.1% |
| BrightSpring Health Services, Inc. Common StockBTSG | $824 thousand | under 0.1% |
| ROIVANT SCIENCES LTD | $803 thousand | under 0.1% |
| Arcutis Biotherapeutics IncARQT | $755 thousand | under 0.1% |
| Axsome Therapeutics IncAXSM | $731 thousand | under 0.1% |
| Cogent Biosciences IncCOGT | $604 thousand | under 0.1% |
| Alkermes PlcALKS | $582 thousand | under 0.1% |
| Insmed IncINSM | $522 thousand | under 0.1% |
| Krystal Biotech IncKRYS | $493 thousand | under 0.1% |
| Progyny IncPGNY | $462 thousand | under 0.1% |
| Travere Therapeutics IncTVTX | $459 thousand | under 0.1% |
| HealthEquity IncHQY | $458 thousand | under 0.1% |
| Celcuity LLCCELC | $399 thousand | under 0.1% |
| Omeros CorporationOMER | $395 thousand | under 0.1% |
| Ionis Pharmaceuticals IncIONS | $380 thousand | under 0.1% |
| Cyberonics IncCYBX | $369 thousand | under 0.1% |
| Globus MedicalGMED | $349 thousand | under 0.1% |
| Cencora Inc.COR | $338 thousand | under 0.1% |
| UNIQURE NV | $335 thousand | under 0.1% |
| BeiGene, Ltd.ONC | $334 thousand | under 0.1% |
| CG Oncology, Inc. Common stockCGON | $332 thousand | under 0.1% |
| Scholar Rock Holding CorpSRRK | $308 thousand | under 0.1% |
| Immunovant IncIMVT | $305 thousand | under 0.1% |
| Nuvalent IncNUVL | $302 thousand | under 0.1% |
| Ascendis Pharma ASASND | $299 thousand | under 0.1% |
| Veracyte IncVCYT | $295 thousand | under 0.1% |
| Glaukos CorpGKOS | $294 thousand | under 0.1% |
| SOLID POWER INC | $287 thousand | under 0.1% |
| Stoke Therapeutics IncSTOK | $286 thousand | under 0.1% |
| Sabra Healthcare REIT IncSBRA | $265 thousand | under 0.1% |
| Merit Medical Systems IncMMSI | $264 thousand | under 0.1% |
| Grifols SA ADRGRFS | $262 thousand | under 0.1% |
| Arcellx IncACLX | $261 thousand | under 0.1% |
| Nuvation Bio IncNUVB | $260 thousand | under 0.1% |
| UROGEN PHARMA LTD | $258 thousand | under 0.1% |
| Pacific Biosciences of CaliforniaPACB | $252 thousand | under 0.1% |
| GE HealthCare Technologies Inc.GEHC | $246 thousand | under 0.1% |
| Twist Bioscience CorpTWST | $243 thousand | under 0.1% |
| Mirum Pharmaceuticals IncMIRM | $237 thousand | under 0.1% |
| Soleno Therapeutics IncSLNO | $232 thousand | under 0.1% |
| Vaxcyte IncPCVX | $231 thousand | under 0.1% |
| Amicus Therapeutics IncFOLD | $228 thousand | under 0.1% |
| AleAnna, Inc. Class A Common StockANNA | $223 thousand | under 0.1% |
| NeoGenomics IncNEO | $223 thousand | under 0.1% |
| ICON PLCICLR | $219 thousand | under 0.1% |
| ESTABLISHMENT LABS HLDGS INC | $219 thousand | under 0.1% |
| Ocular Therapeutix IncOCUL | $219 thousand | under 0.1% |
| Syndax Pharmaceuticals IncSNDX | $210 thousand | under 0.1% |
| Precigen IncPGEN | $209 thousand | under 0.1% |
| Healthcare Realty Trust IncorporatedHR | $203 thousand | under 0.1% |
| Dyne Therapeutics IncDYN | $196 thousand | under 0.1% |
| BioCryst Pharmaceuticals IncBCRX | $187 thousand | under 0.1% |
| Tvardi Therapeutics, Inc.TVRD | $186 thousand | under 0.1% |
| Adaptive Biotechnologies CorpADPT | $179 thousand | under 0.1% |
| ALEANNA INC | $163 thousand | under 0.1% |
| Ardelyx IncARDX | $134 thousand | under 0.1% |
| BLUE GOLD LTD | $132 thousand | under 0.1% |
| REVOLUTION MEDICINES INC | $113 thousand | under 0.1% |
| Rani Therapeutics Holdings IncRANI | $105 thousand | under 0.1% |
| Altimmune IncALT | $100 thousand | under 0.1% |
| Iovance Biotherapeutics IncIOVA | $71 thousand | under 0.1% |
| Geron CorporationGERN | $57 thousand | under 0.1% |
| Evolent Health IncEVH | $56 thousand | under 0.1% |
| C4 Therapeutics IncCCCC | $53 thousand | under 0.1% |
| Ironwood Pharmaceuticals IncIRWD | $44 thousand | under 0.1% |
| Canopy Growth CorpCGC | $34 thousand | under 0.1% |
| NVNI GROUP LIMITED | $23 thousand | under 0.1% |
| Beyond Meat IncBYND | $16 thousand | under 0.1% |
What changed last quarter
Compared with the previous reported quarter. Additions and trims count shares, so a move in the share price alone is not a change. 61 positions were held with the same number of shares.
New positions
- CyberArk Software Ltd (CYBR)$469.7 million
- Synopsys Inc (SNPS)$469.3 million
- Broadcom Inc (AVGO)$308.9 million
- KKR & Co. Inc. (KKR)$257.2 million
- Dayforce Inc. (DAY)$202.3 million
- Bitwise 10 Crypto Index ETF (BITW)$198.9 million
- Welltower Inc (WELL)$63.7 million
- Structure Therapeutics Inc. American Depositary Shares (GPCR)$31.6 million
- SUNOCOCORP LLC$29.9 million
- PERCEPTIVE CAP SOLUTIONS COR$29.3 million
And 18 more.
Added to
- Microsoft Corporation (MSFT)shares up 15.7%
- Amazon.com Inc (AMZN)shares up 28.4%
- Aon PLC (AON)shares up 17.0%
- Boston Scientific Corp (BSX)shares up 56.7%
- BridgeBio Pharma Inc (BBIO)shares up 9.8%
- Westinghouse Air Brake Technologies Corp (WAB)shares up 12.3%
- Lantheus Holdings Inc (LNTH)shares up 56.1%
- Aramark Holdings (ARMK)shares up 4.0%
- Charles Schwab Corp (SCHW)shares up 2.7%
- Crinetics Pharmaceuticals Inc (CRNX)shares up 20.2%
And 12 more.
Trimmed
- Exelixis Inc (EXEL)shares down 19.4%
- Natera Inc (NTRA)shares down 8.0%
- Revolution Medicines Inc (RVMD)shares down 0.3%
- UnitedHealth Group Incorporated (UNH)shares down 15.2%
- Thermo Fisher Scientific Inc (TMO)shares down 49.5%
- Hims Hers Health Inc (HIMS)shares down 68.5%
- Walt Disney Company (DIS)shares down 20.6%
- Salesforce.com Inc (CRM)shares down 48.8%
- iShares iBonds 1-5 Year Corporate Ladder ETF (IBIT)shares down 69.4%
- Protagonist Therapeutics Inc (PTGX)shares down 0.8%
And 24 more.
Exited
- Autodesk Inc (ADSK)was $528.2 million
- Intuit Inc (INTU)was $333.3 million
- KELLANOVAwas $323.5 million
- Analog Devices Inc (ADI)was $319.3 million
- Norfolk Southern Corporation (NSC)was $184.8 million
- IQVIA Holdings Inc (IQV)was $178.3 million
- Woodward Inc (WWD)was $157.2 million
- Marathon Digital Holdings Inc (MARA)was $66.8 million
- GRAYSCALE COINDESK CRYPTOwas $47.6 million
- MR COOPER GROUP INCwas $46.8 million
And 12 more.
How the score works
The consistency score takes the positions each 13F reports, weighted by their share of the book, and measures how they performed over the 90 days after the filing became public. It then compares that result with every other eligible manager’s filing for the same quarter, and rewards beating them repeatedly more than one strong quarter.
- Up to 20 completed quarters count. A manager is ranked once it has at least twelve, with an average of at least 80% of the book priced across them.
- A quarter counts when at least 70% of its book maps to listed securities with daily prices, and when at least 20 managers have a completed quarter to compare.
- At least a quarter of the book must sit in its ten largest positions, because a book spread across thousands of names describes the market more than the manager.
- Options, exchange-traded funds and other funds stay in the holdings table and are left out of the score.
- When a filing is restated, the restatement replaces the original, so each quarter counts once.
- Operating companies, sovereign funds, pensions, venture capital firms, private equity sponsors and banks are not ranked.
The one-year figure compounds the last four completed 90-day windows. A filing counts once its window has closed, so a new filing moves neither number on the day it arrives.
Source: SEC Form 13F filings by Farallon Capital Management (CIK 909661). Holdings as filed for the quarter ending 31 December 2025, valued as reported; returns use daily closing prices. The ranking of 16 September 2026 covers 978 managers.